DEHYDROLATANOPROST
DEHYDROLATANOPROST is a cosmetic ingredient. Also known as CAS 130209-76-6. It is regulated in 1 market including Canada.
Also Known As
- CAS Number
- 130209-76-6
Market Overview — 29 Markets
Detailed Regulations
EuropeNo restrictions
No specific restrictions for DEHYDROLATANOPROST in European Union, United Kingdom.
Americas1 regulation
- Chemical name
- Prostaglandins, their salts and derivatives and their analogs
- CAS
- 130209-76-6
- Conditions of use
- Prohibited in cosmetics
Source: Health Canada Cosmetic Ingredient Hotlist
East Asia & OceaniaNo restrictions
No specific restrictions for DEHYDROLATANOPROST in South Korea, Japan, Taiwan, Australia.
ASEANNo restrictions
No specific restrictions for DEHYDROLATANOPROST in Singapore, Malaysia, Thailand, Indonesia, Vietnam, Philippines.
GCCNo restrictions
No specific restrictions for DEHYDROLATANOPROST in UAE, Saudi Arabia, Qatar, Oman, Kuwait, Bahrain.
EAEUNo restrictions
No specific restrictions for DEHYDROLATANOPROST in Russia, Belarus, Kazakhstan, Armenia, Kyrgyzstan.
Frequently Asked Questions
Is DEHYDROLATANOPROST banned in any country?
Yes, DEHYDROLATANOPROST is banned in Canada. Always check current regulations before formulating products for these markets.
What are the restrictions on DEHYDROLATANOPROST in cosmetics?
DEHYDROLATANOPROST is banned in Canada and has no specific restrictions in other tracked markets.
Can I use DEHYDROLATANOPROST in cosmetics?
DEHYDROLATANOPROST is regulated in 1 market. It is banned in Canada. Use Formpli's free screening tool to check your full ingredient list against all 26 markets at once.
Screen DEHYDROLATANOPROST with your full formula
Paste your entire ingredient list and get a compliance report across 26 markets — free, no signup.
Check Ingredients FreeThis information is for reference only and does not constitute legal or regulatory advice. Regulations change — always verify with official sources and consult a regulatory specialist before exporting cosmetic products. Data sourced from EU COSING, US FDA, Health Canada, MHLW Japan, MFDS Korea, ASEAN ACD, GCC SFDA, TGA Australia, ANVISA Brazil, EAEU TR CU, and Taiwan TFDA.